- Home
- FRPT vs CORT Comparison
FRPT vs CORT Comparison
Compare FRPT & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FRPT | CORT |
|---|---|---|
| Founded | 2004 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 7.6B |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | FRPT | CORT |
|---|---|---|
| Price | $65.83 | $82.08 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 6 |
| Target Price | $76.57 | ★ $130.20 |
| AVG Volume (30 Days) | ★ 1.2M | 852.0K |
| Earning Date | 11-03-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 169.38 | N/A |
| EPS | ★ 2.38 | 0.87 |
| Revenue | ★ $1,079,494,000.00 | $741,172,000.00 |
| Revenue This Year | $15.47 | $23.79 |
| Revenue Next Year | $9.95 | $40.97 |
| P/E Ratio | ★ $27.23 | $94.20 |
| Revenue Growth | 16.34 | ★ 17.92 |
| 52 Week Low | $46.76 | $49.00 |
| 52 Week High | $164.07 | $117.33 |
Technical Indicators
Market Signals| Indicator | FRPT | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 72.34 | 51.07 |
| Support Level | $62.85 | $78.07 |
| Resistance Level | $65.75 | $89.00 |
| Average True Range (ATR) | 2.37 | 3.47 |
| MACD | 0.30 | -0.31 |
| Stochastic Oscillator | 90.29 | 37.54 |
Price Performance
Historical ComparisonAbout FRPT Freshpet Inc.
Freshpet produces and sells premium fresh pet food through its company-owned refrigerators placed in grocery, mass and club, pet specialty, and natural stores. Freshpet primarily targets dogs (96% of 2024 sales), with cats and treats comprising the rest of its sales. Geographically, the company's home US market, where all its food is produced, accounts for about 98% of sales, with exports to Canada, the United Kingdom, and other European countries accounting for the remaining balance.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.